Rare diseases
Investigational molecules
Locations
469 conditions with trials, the busiest first
1 123 trials across Europe, recruiting first
Safety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome
BelgiumStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
AustriaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
AustriaStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
BulgariaStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
BulgariaStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
AustriaStudy of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
AustriaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
AustriaA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
BelgiumA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
AustriaEvaluation of Safety, Tolerability, and Biodistribution of Inhaled RCT2100 in Cystic Fibrosis: A Phase 1/2 Multicenter Study
FranceThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
